nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—ABCB1—peripheral nervous system neoplasm	0.282	1	CbGaD
Citalopram—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0532	0.128	CbGbCtD
Citalopram—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0464	0.111	CbGbCtD
Citalopram—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0336	0.0805	CbGbCtD
Citalopram—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0294	0.0704	CbGbCtD
Citalopram—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0294	0.0704	CbGbCtD
Citalopram—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0268	0.0644	CbGbCtD
Citalopram—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0228	0.0547	CbGbCtD
Citalopram—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0227	0.0545	CbGbCtD
Citalopram—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0203	0.0488	CbGbCtD
Citalopram—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0176	0.0422	CbGbCtD
Citalopram—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0164	0.0392	CbGbCtD
Citalopram—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0153	0.0366	CbGbCtD
Citalopram—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0131	0.0315	CbGbCtD
Citalopram—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0125	0.0301	CbGbCtD
Citalopram—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0117	0.028	CbGbCtD
Citalopram—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0115	0.0275	CbGbCtD
Citalopram—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00783	0.0188	CbGbCtD
Citalopram—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00751	0.018	CbGbCtD
Citalopram—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00738	0.0177	CbGbCtD
Citalopram—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00688	0.0165	CbGbCtD
Citalopram—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00469	0.0113	CbGbCtD
Citalopram—Stomatitis—Epirubicin—peripheral nervous system neoplasm	4.56e-05	0.000154	CcSEcCtD
Citalopram—Jaundice—Epirubicin—peripheral nervous system neoplasm	4.56e-05	0.000154	CcSEcCtD
Citalopram—Pain—Etoposide—peripheral nervous system neoplasm	4.55e-05	0.000154	CcSEcCtD
Citalopram—Constipation—Etoposide—peripheral nervous system neoplasm	4.55e-05	0.000154	CcSEcCtD
Citalopram—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	4.55e-05	0.000154	CcSEcCtD
Citalopram—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	4.55e-05	0.000154	CcSEcCtD
Citalopram—Dysuria—Doxorubicin—peripheral nervous system neoplasm	4.54e-05	0.000154	CcSEcCtD
Citalopram—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	4.51e-05	0.000153	CcSEcCtD
Citalopram—Dizziness—Alitretinoin—peripheral nervous system neoplasm	4.51e-05	0.000153	CcSEcCtD
Citalopram—Diarrhoea—Vincristine—peripheral nervous system neoplasm	4.5e-05	0.000152	CcSEcCtD
Citalopram—Sweating—Epirubicin—peripheral nervous system neoplasm	4.49e-05	0.000152	CcSEcCtD
Citalopram—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	4.49e-05	0.000152	CcSEcCtD
Citalopram—Haematuria—Epirubicin—peripheral nervous system neoplasm	4.46e-05	0.000151	CcSEcCtD
Citalopram—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.00015	CcSEcCtD
Citalopram—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	4.43e-05	0.00015	CcSEcCtD
Citalopram—Weight increased—Doxorubicin—peripheral nervous system neoplasm	4.42e-05	0.000149	CcSEcCtD
Citalopram—Epistaxis—Epirubicin—peripheral nervous system neoplasm	4.41e-05	0.000149	CcSEcCtD
Citalopram—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	4.39e-05	0.000149	CcSEcCtD
Citalopram—Sinusitis—Epirubicin—peripheral nervous system neoplasm	4.39e-05	0.000149	CcSEcCtD
Citalopram—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	4.39e-05	0.000148	CcSEcCtD
Citalopram—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	4.38e-05	0.000148	CcSEcCtD
Citalopram—Nausea—Dactinomycin—peripheral nervous system neoplasm	4.37e-05	0.000148	CcSEcCtD
Citalopram—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	4.37e-05	0.000148	CcSEcCtD
Citalopram—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	4.36e-05	0.000147	CcSEcCtD
Citalopram—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	4.35e-05	0.000147	CcSEcCtD
Citalopram—Dizziness—Vincristine—peripheral nervous system neoplasm	4.35e-05	0.000147	CcSEcCtD
Citalopram—Vomiting—Alitretinoin—peripheral nervous system neoplasm	4.34e-05	0.000147	CcSEcCtD
Citalopram—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	4.33e-05	0.000146	CcSEcCtD
Citalopram—Infestation—Doxorubicin—peripheral nervous system neoplasm	4.33e-05	0.000146	CcSEcCtD
Citalopram—Rash—Alitretinoin—peripheral nervous system neoplasm	4.3e-05	0.000145	CcSEcCtD
Citalopram—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	4.3e-05	0.000145	CcSEcCtD
Citalopram—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	4.29e-05	0.000145	CcSEcCtD
Citalopram—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	4.28e-05	0.000145	CcSEcCtD
Citalopram—Bradycardia—Epirubicin—peripheral nervous system neoplasm	4.28e-05	0.000145	CcSEcCtD
Citalopram—Headache—Alitretinoin—peripheral nervous system neoplasm	4.27e-05	0.000145	CcSEcCtD
Citalopram—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	4.24e-05	0.000144	CcSEcCtD
Citalopram—Urticaria—Etoposide—peripheral nervous system neoplasm	4.23e-05	0.000143	CcSEcCtD
Citalopram—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	4.22e-05	0.000143	CcSEcCtD
Citalopram—Jaundice—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000143	CcSEcCtD
Citalopram—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000143	CcSEcCtD
Citalopram—Rhinitis—Epirubicin—peripheral nervous system neoplasm	4.21e-05	0.000142	CcSEcCtD
Citalopram—Abdominal pain—Etoposide—peripheral nervous system neoplasm	4.21e-05	0.000142	CcSEcCtD
Citalopram—Body temperature increased—Etoposide—peripheral nervous system neoplasm	4.21e-05	0.000142	CcSEcCtD
Citalopram—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	4.21e-05	0.000142	CcSEcCtD
Citalopram—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	4.21e-05	0.000142	CcSEcCtD
Citalopram—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	4.2e-05	0.000142	CcSEcCtD
Citalopram—Hepatitis—Epirubicin—peripheral nervous system neoplasm	4.2e-05	0.000142	CcSEcCtD
Citalopram—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	4.18e-05	0.000141	CcSEcCtD
Citalopram—Vomiting—Vincristine—peripheral nervous system neoplasm	4.18e-05	0.000141	CcSEcCtD
Citalopram—Asthenia—Cisplatin—peripheral nervous system neoplasm	4.17e-05	0.000141	CcSEcCtD
Citalopram—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	4.17e-05	0.000141	CcSEcCtD
Citalopram—Sweating—Doxorubicin—peripheral nervous system neoplasm	4.15e-05	0.00014	CcSEcCtD
Citalopram—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	4.15e-05	0.00014	CcSEcCtD
Citalopram—Rash—Vincristine—peripheral nervous system neoplasm	4.14e-05	0.00014	CcSEcCtD
Citalopram—Dermatitis—Vincristine—peripheral nervous system neoplasm	4.14e-05	0.00014	CcSEcCtD
Citalopram—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	4.14e-05	0.00014	CcSEcCtD
Citalopram—Haematuria—Doxorubicin—peripheral nervous system neoplasm	4.13e-05	0.00014	CcSEcCtD
Citalopram—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	4.13e-05	0.00014	CcSEcCtD
Citalopram—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	4.12e-05	0.000139	CcSEcCtD
Citalopram—Headache—Vincristine—peripheral nervous system neoplasm	4.12e-05	0.000139	CcSEcCtD
Citalopram—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	4.1e-05	0.000139	CcSEcCtD
Citalopram—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	4.08e-05	0.000138	CcSEcCtD
Citalopram—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	4.06e-05	0.000137	CcSEcCtD
Citalopram—Nausea—Alitretinoin—peripheral nervous system neoplasm	4.05e-05	0.000137	CcSEcCtD
Citalopram—Visual impairment—Epirubicin—peripheral nervous system neoplasm	4.05e-05	0.000137	CcSEcCtD
Citalopram—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	4.04e-05	0.000137	CcSEcCtD
Citalopram—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	3.98e-05	0.000135	CcSEcCtD
Citalopram—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	3.97e-05	0.000134	CcSEcCtD
Citalopram—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	3.96e-05	0.000134	CcSEcCtD
Citalopram—Eye disorder—Epirubicin—peripheral nervous system neoplasm	3.93e-05	0.000133	CcSEcCtD
Citalopram—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	3.92e-05	0.000133	CcSEcCtD
Citalopram—Tinnitus—Epirubicin—peripheral nervous system neoplasm	3.92e-05	0.000132	CcSEcCtD
Citalopram—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	3.91e-05	0.000132	CcSEcCtD
Citalopram—Nausea—Vincristine—peripheral nervous system neoplasm	3.9e-05	0.000132	CcSEcCtD
Citalopram—Flushing—Epirubicin—peripheral nervous system neoplasm	3.9e-05	0.000132	CcSEcCtD
Citalopram—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	3.9e-05	0.000132	CcSEcCtD
Citalopram—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	3.9e-05	0.000132	CcSEcCtD
Citalopram—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	3.89e-05	0.000131	CcSEcCtD
Citalopram—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	3.89e-05	0.000131	CcSEcCtD
Citalopram—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	3.87e-05	0.000131	CcSEcCtD
Citalopram—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	3.86e-05	0.000131	CcSEcCtD
Citalopram—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	3.84e-05	0.00013	CcSEcCtD
Citalopram—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	3.83e-05	0.00013	CcSEcCtD
Citalopram—Asthenia—Etoposide—peripheral nervous system neoplasm	3.82e-05	0.000129	CcSEcCtD
Citalopram—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	3.82e-05	0.000129	CcSEcCtD
Citalopram—Angiopathy—Epirubicin—peripheral nervous system neoplasm	3.81e-05	0.000129	CcSEcCtD
Citalopram—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	3.81e-05	0.000129	CcSEcCtD
Citalopram—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	3.79e-05	0.000128	CcSEcCtD
Citalopram—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	3.79e-05	0.000128	CcSEcCtD
Citalopram—Chills—Epirubicin—peripheral nervous system neoplasm	3.77e-05	0.000128	CcSEcCtD
Citalopram—Pruritus—Etoposide—peripheral nervous system neoplasm	3.77e-05	0.000127	CcSEcCtD
Citalopram—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	3.75e-05	0.000127	CcSEcCtD
Citalopram—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	3.75e-05	0.000127	CcSEcCtD
Citalopram—Alopecia—Epirubicin—peripheral nervous system neoplasm	3.71e-05	0.000126	CcSEcCtD
Citalopram—Vomiting—Cisplatin—peripheral nervous system neoplasm	3.7e-05	0.000125	CcSEcCtD
Citalopram—Mental disorder—Epirubicin—peripheral nervous system neoplasm	3.68e-05	0.000124	CcSEcCtD
Citalopram—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	3.68e-05	0.000124	CcSEcCtD
Citalopram—Rash—Cisplatin—peripheral nervous system neoplasm	3.66e-05	0.000124	CcSEcCtD
Citalopram—Dermatitis—Cisplatin—peripheral nervous system neoplasm	3.66e-05	0.000124	CcSEcCtD
Citalopram—Malnutrition—Epirubicin—peripheral nervous system neoplasm	3.66e-05	0.000124	CcSEcCtD
Citalopram—Erythema—Epirubicin—peripheral nervous system neoplasm	3.66e-05	0.000124	CcSEcCtD
Citalopram—Diarrhoea—Etoposide—peripheral nervous system neoplasm	3.64e-05	0.000123	CcSEcCtD
Citalopram—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	3.63e-05	0.000123	CcSEcCtD
Citalopram—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	3.62e-05	0.000123	CcSEcCtD
Citalopram—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	3.61e-05	0.000122	CcSEcCtD
Citalopram—Flushing—Doxorubicin—peripheral nervous system neoplasm	3.61e-05	0.000122	CcSEcCtD
Citalopram—Flatulence—Epirubicin—peripheral nervous system neoplasm	3.6e-05	0.000122	CcSEcCtD
Citalopram—Tension—Epirubicin—peripheral nervous system neoplasm	3.59e-05	0.000121	CcSEcCtD
Citalopram—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	3.58e-05	0.000121	CcSEcCtD
Citalopram—Nervousness—Epirubicin—peripheral nervous system neoplasm	3.55e-05	0.00012	CcSEcCtD
Citalopram—Back pain—Epirubicin—peripheral nervous system neoplasm	3.54e-05	0.00012	CcSEcCtD
Citalopram—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	3.53e-05	0.000119	CcSEcCtD
Citalopram—Dizziness—Etoposide—peripheral nervous system neoplasm	3.52e-05	0.000119	CcSEcCtD
Citalopram—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	3.52e-05	0.000119	CcSEcCtD
Citalopram—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	3.51e-05	0.000119	CcSEcCtD
Citalopram—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.5e-05	0.000119	CcSEcCtD
Citalopram—Chills—Doxorubicin—peripheral nervous system neoplasm	3.49e-05	0.000118	CcSEcCtD
Citalopram—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	3.47e-05	0.000117	CcSEcCtD
Citalopram—Nausea—Cisplatin—peripheral nervous system neoplasm	3.45e-05	0.000117	CcSEcCtD
Citalopram—Vision blurred—Epirubicin—peripheral nervous system neoplasm	3.45e-05	0.000117	CcSEcCtD
Citalopram—Alopecia—Doxorubicin—peripheral nervous system neoplasm	3.44e-05	0.000116	CcSEcCtD
Citalopram—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	3.41e-05	0.000115	CcSEcCtD
Citalopram—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	3.39e-05	0.000115	CcSEcCtD
Citalopram—Vomiting—Etoposide—peripheral nervous system neoplasm	3.39e-05	0.000115	CcSEcCtD
Citalopram—Erythema—Doxorubicin—peripheral nervous system neoplasm	3.38e-05	0.000114	CcSEcCtD
Citalopram—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	3.38e-05	0.000114	CcSEcCtD
Citalopram—Anaemia—Epirubicin—peripheral nervous system neoplasm	3.38e-05	0.000114	CcSEcCtD
Citalopram—Agitation—Epirubicin—peripheral nervous system neoplasm	3.36e-05	0.000114	CcSEcCtD
Citalopram—Rash—Etoposide—peripheral nervous system neoplasm	3.36e-05	0.000114	CcSEcCtD
Citalopram—Dermatitis—Etoposide—peripheral nervous system neoplasm	3.35e-05	0.000113	CcSEcCtD
Citalopram—Headache—Etoposide—peripheral nervous system neoplasm	3.34e-05	0.000113	CcSEcCtD
Citalopram—Flatulence—Doxorubicin—peripheral nervous system neoplasm	3.33e-05	0.000113	CcSEcCtD
Citalopram—Tension—Doxorubicin—peripheral nervous system neoplasm	3.32e-05	0.000112	CcSEcCtD
Citalopram—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	3.31e-05	0.000112	CcSEcCtD
Citalopram—Malaise—Epirubicin—peripheral nervous system neoplasm	3.3e-05	0.000112	CcSEcCtD
Citalopram—Nervousness—Doxorubicin—peripheral nervous system neoplasm	3.29e-05	0.000111	CcSEcCtD
Citalopram—Vertigo—Epirubicin—peripheral nervous system neoplasm	3.29e-05	0.000111	CcSEcCtD
Citalopram—Syncope—Epirubicin—peripheral nervous system neoplasm	3.28e-05	0.000111	CcSEcCtD
Citalopram—Leukopenia—Epirubicin—peripheral nervous system neoplasm	3.27e-05	0.000111	CcSEcCtD
Citalopram—Back pain—Doxorubicin—peripheral nervous system neoplasm	3.27e-05	0.000111	CcSEcCtD
Citalopram—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	3.25e-05	0.00011	CcSEcCtD
Citalopram—Palpitations—Epirubicin—peripheral nervous system neoplasm	3.23e-05	0.000109	CcSEcCtD
Citalopram—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	3.21e-05	0.000109	CcSEcCtD
Citalopram—Cough—Epirubicin—peripheral nervous system neoplasm	3.19e-05	0.000108	CcSEcCtD
Citalopram—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	3.19e-05	0.000108	CcSEcCtD
Citalopram—Convulsion—Epirubicin—peripheral nervous system neoplasm	3.17e-05	0.000107	CcSEcCtD
Citalopram—Nausea—Etoposide—peripheral nervous system neoplasm	3.16e-05	0.000107	CcSEcCtD
Citalopram—Hypertension—Epirubicin—peripheral nervous system neoplasm	3.16e-05	0.000107	CcSEcCtD
Citalopram—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	3.14e-05	0.000106	CcSEcCtD
Citalopram—Anaemia—Doxorubicin—peripheral nervous system neoplasm	3.13e-05	0.000106	CcSEcCtD
Citalopram—Arthralgia—Epirubicin—peripheral nervous system neoplasm	3.11e-05	0.000105	CcSEcCtD
Citalopram—Chest pain—Epirubicin—peripheral nervous system neoplasm	3.11e-05	0.000105	CcSEcCtD
Citalopram—Myalgia—Epirubicin—peripheral nervous system neoplasm	3.11e-05	0.000105	CcSEcCtD
Citalopram—Agitation—Doxorubicin—peripheral nervous system neoplasm	3.11e-05	0.000105	CcSEcCtD
Citalopram—Anxiety—Epirubicin—peripheral nervous system neoplasm	3.1e-05	0.000105	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	3.09e-05	0.000105	CcSEcCtD
Citalopram—Discomfort—Epirubicin—peripheral nervous system neoplasm	3.08e-05	0.000104	CcSEcCtD
Citalopram—Malaise—Doxorubicin—peripheral nervous system neoplasm	3.05e-05	0.000103	CcSEcCtD
Citalopram—Dry mouth—Epirubicin—peripheral nervous system neoplasm	3.05e-05	0.000103	CcSEcCtD
Citalopram—Vertigo—Doxorubicin—peripheral nervous system neoplasm	3.04e-05	0.000103	CcSEcCtD
Citalopram—Syncope—Doxorubicin—peripheral nervous system neoplasm	3.03e-05	0.000103	CcSEcCtD
Citalopram—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	3.03e-05	0.000102	CcSEcCtD
Citalopram—Confusional state—Epirubicin—peripheral nervous system neoplasm	3.01e-05	0.000102	CcSEcCtD
Citalopram—Palpitations—Doxorubicin—peripheral nervous system neoplasm	2.99e-05	0.000101	CcSEcCtD
Citalopram—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	2.98e-05	0.000101	CcSEcCtD
Citalopram—Oedema—Epirubicin—peripheral nervous system neoplasm	2.98e-05	0.000101	CcSEcCtD
Citalopram—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	2.97e-05	0.000101	CcSEcCtD
Citalopram—Infection—Epirubicin—peripheral nervous system neoplasm	2.97e-05	0.0001	CcSEcCtD
Citalopram—Cough—Doxorubicin—peripheral nervous system neoplasm	2.95e-05	9.99e-05	CcSEcCtD
Citalopram—Shock—Epirubicin—peripheral nervous system neoplasm	2.94e-05	9.93e-05	CcSEcCtD
Citalopram—Convulsion—Doxorubicin—peripheral nervous system neoplasm	2.93e-05	9.92e-05	CcSEcCtD
Citalopram—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	2.93e-05	9.9e-05	CcSEcCtD
Citalopram—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	2.92e-05	9.89e-05	CcSEcCtD
Citalopram—Hypertension—Doxorubicin—peripheral nervous system neoplasm	2.92e-05	9.88e-05	CcSEcCtD
Citalopram—Tachycardia—Epirubicin—peripheral nervous system neoplasm	2.91e-05	9.85e-05	CcSEcCtD
Citalopram—Skin disorder—Epirubicin—peripheral nervous system neoplasm	2.9e-05	9.81e-05	CcSEcCtD
Citalopram—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	2.89e-05	9.76e-05	CcSEcCtD
Citalopram—Chest pain—Doxorubicin—peripheral nervous system neoplasm	2.88e-05	9.74e-05	CcSEcCtD
Citalopram—Myalgia—Doxorubicin—peripheral nervous system neoplasm	2.88e-05	9.74e-05	CcSEcCtD
Citalopram—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	2.88e-05	9.74e-05	CcSEcCtD
Citalopram—Anxiety—Doxorubicin—peripheral nervous system neoplasm	2.87e-05	9.71e-05	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	2.86e-05	9.68e-05	CcSEcCtD
Citalopram—Discomfort—Doxorubicin—peripheral nervous system neoplasm	2.85e-05	9.63e-05	CcSEcCtD
Citalopram—Anorexia—Epirubicin—peripheral nervous system neoplasm	2.85e-05	9.62e-05	CcSEcCtD
Citalopram—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	2.82e-05	9.53e-05	CcSEcCtD
Citalopram—Hypotension—Epirubicin—peripheral nervous system neoplasm	2.79e-05	9.43e-05	CcSEcCtD
Citalopram—Confusional state—Doxorubicin—peripheral nervous system neoplasm	2.78e-05	9.42e-05	CcSEcCtD
Citalopram—Oedema—Doxorubicin—peripheral nervous system neoplasm	2.76e-05	9.34e-05	CcSEcCtD
Citalopram—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	2.76e-05	9.34e-05	CcSEcCtD
Citalopram—Infection—Doxorubicin—peripheral nervous system neoplasm	2.74e-05	9.28e-05	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	2.72e-05	9.2e-05	CcSEcCtD
Citalopram—Shock—Doxorubicin—peripheral nervous system neoplasm	2.72e-05	9.19e-05	CcSEcCtD
Citalopram—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	2.71e-05	9.16e-05	CcSEcCtD
Citalopram—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	2.7e-05	9.15e-05	CcSEcCtD
Citalopram—Insomnia—Epirubicin—peripheral nervous system neoplasm	2.7e-05	9.13e-05	CcSEcCtD
Citalopram—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	2.7e-05	9.12e-05	CcSEcCtD
Citalopram—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	2.68e-05	9.07e-05	CcSEcCtD
Citalopram—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	2.68e-05	9.07e-05	CcSEcCtD
Citalopram—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	2.67e-05	9.03e-05	CcSEcCtD
Citalopram—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	2.66e-05	9e-05	CcSEcCtD
Citalopram—Somnolence—Epirubicin—peripheral nervous system neoplasm	2.65e-05	8.98e-05	CcSEcCtD
Citalopram—Anorexia—Doxorubicin—peripheral nervous system neoplasm	2.63e-05	8.9e-05	CcSEcCtD
Citalopram—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	2.63e-05	8.89e-05	CcSEcCtD
Citalopram—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	2.59e-05	8.78e-05	CcSEcCtD
Citalopram—Hypotension—Doxorubicin—peripheral nervous system neoplasm	2.58e-05	8.73e-05	CcSEcCtD
Citalopram—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	2.58e-05	8.72e-05	CcSEcCtD
Citalopram—Fatigue—Epirubicin—peripheral nervous system neoplasm	2.57e-05	8.7e-05	CcSEcCtD
Citalopram—Pain—Epirubicin—peripheral nervous system neoplasm	2.55e-05	8.63e-05	CcSEcCtD
Citalopram—Constipation—Epirubicin—peripheral nervous system neoplasm	2.55e-05	8.63e-05	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	2.52e-05	8.51e-05	CcSEcCtD
Citalopram—Insomnia—Doxorubicin—peripheral nervous system neoplasm	2.5e-05	8.45e-05	CcSEcCtD
Citalopram—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	2.48e-05	8.39e-05	CcSEcCtD
Citalopram—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	2.46e-05	8.33e-05	CcSEcCtD
Citalopram—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	2.46e-05	8.32e-05	CcSEcCtD
Citalopram—Somnolence—Doxorubicin—peripheral nervous system neoplasm	2.46e-05	8.3e-05	CcSEcCtD
Citalopram—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	2.44e-05	8.26e-05	CcSEcCtD
Citalopram—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	2.43e-05	8.22e-05	CcSEcCtD
Citalopram—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	2.4e-05	8.12e-05	CcSEcCtD
Citalopram—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	2.38e-05	8.06e-05	CcSEcCtD
Citalopram—Fatigue—Doxorubicin—peripheral nervous system neoplasm	2.38e-05	8.05e-05	CcSEcCtD
Citalopram—Urticaria—Epirubicin—peripheral nervous system neoplasm	2.37e-05	8.02e-05	CcSEcCtD
Citalopram—Pain—Doxorubicin—peripheral nervous system neoplasm	2.36e-05	7.99e-05	CcSEcCtD
Citalopram—Constipation—Doxorubicin—peripheral nervous system neoplasm	2.36e-05	7.99e-05	CcSEcCtD
Citalopram—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	2.36e-05	7.98e-05	CcSEcCtD
Citalopram—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	2.36e-05	7.98e-05	CcSEcCtD
Citalopram—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	2.28e-05	7.7e-05	CcSEcCtD
Citalopram—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	2.26e-05	7.64e-05	CcSEcCtD
Citalopram—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	2.2e-05	7.44e-05	CcSEcCtD
Citalopram—Urticaria—Doxorubicin—peripheral nervous system neoplasm	2.19e-05	7.42e-05	CcSEcCtD
Citalopram—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	2.18e-05	7.38e-05	CcSEcCtD
Citalopram—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.18e-05	7.38e-05	CcSEcCtD
Citalopram—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.14e-05	7.24e-05	CcSEcCtD
Citalopram—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.11e-05	7.14e-05	CcSEcCtD
Citalopram—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.04e-05	6.91e-05	CcSEcCtD
Citalopram—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2.03e-05	6.88e-05	CcSEcCtD
Citalopram—Asthenia—Doxorubicin—peripheral nervous system neoplasm	1.98e-05	6.7e-05	CcSEcCtD
Citalopram—Dizziness—Epirubicin—peripheral nervous system neoplasm	1.97e-05	6.68e-05	CcSEcCtD
Citalopram—Pruritus—Doxorubicin—peripheral nervous system neoplasm	1.95e-05	6.61e-05	CcSEcCtD
Citalopram—Vomiting—Epirubicin—peripheral nervous system neoplasm	1.9e-05	6.42e-05	CcSEcCtD
Citalopram—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	1.89e-05	6.39e-05	CcSEcCtD
Citalopram—Rash—Epirubicin—peripheral nervous system neoplasm	1.88e-05	6.37e-05	CcSEcCtD
Citalopram—Dermatitis—Epirubicin—peripheral nervous system neoplasm	1.88e-05	6.36e-05	CcSEcCtD
Citalopram—Headache—Epirubicin—peripheral nervous system neoplasm	1.87e-05	6.32e-05	CcSEcCtD
Citalopram—Dizziness—Doxorubicin—peripheral nervous system neoplasm	1.83e-05	6.18e-05	CcSEcCtD
Citalopram—Nausea—Epirubicin—peripheral nervous system neoplasm	1.77e-05	6e-05	CcSEcCtD
Citalopram—Vomiting—Doxorubicin—peripheral nervous system neoplasm	1.76e-05	5.94e-05	CcSEcCtD
Citalopram—Rash—Doxorubicin—peripheral nervous system neoplasm	1.74e-05	5.89e-05	CcSEcCtD
Citalopram—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	1.74e-05	5.88e-05	CcSEcCtD
Citalopram—Headache—Doxorubicin—peripheral nervous system neoplasm	1.73e-05	5.85e-05	CcSEcCtD
Citalopram—Nausea—Doxorubicin—peripheral nervous system neoplasm	1.64e-05	5.55e-05	CcSEcCtD
Citalopram—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	1.03e-05	0.00207	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	1.02e-05	0.00205	CbGpPWpGaD
Citalopram—ADRA1A—AMPK Signaling—TP53—peripheral nervous system neoplasm	1e-05	0.00201	CbGpPWpGaD
Citalopram—SLC6A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	9.99e-06	0.002	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	9.72e-06	0.00195	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	9.57e-06	0.00192	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	9.47e-06	0.0019	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	9.44e-06	0.00189	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	9.3e-06	0.00186	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	9.29e-06	0.00186	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	9.12e-06	0.00183	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	9.08e-06	0.00182	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	9.05e-06	0.00181	CbGpPWpGaD
Citalopram—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	9.01e-06	0.00181	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	8.94e-06	0.00179	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	8.91e-06	0.00179	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	8.91e-06	0.00179	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	8.9e-06	0.00178	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.85e-06	0.00177	CbGpPWpGaD
Citalopram—SLC6A3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	8.85e-06	0.00177	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	8.77e-06	0.00176	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	8.65e-06	0.00173	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.64e-06	0.00173	CbGpPWpGaD
Citalopram—ADRA1A—AMPK Signaling—AKT1—peripheral nervous system neoplasm	8.46e-06	0.0017	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	8.37e-06	0.00168	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	8.31e-06	0.00167	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	8.29e-06	0.00166	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—VIP—peripheral nervous system neoplasm	8.29e-06	0.00166	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	8.27e-06	0.00166	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.14e-06	0.00163	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	8.14e-06	0.00163	CbGpPWpGaD
Citalopram—SLC6A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	8.04e-06	0.00161	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.91e-06	0.00159	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	7.91e-06	0.00158	CbGpPWpGaD
Citalopram—SLC6A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	7.89e-06	0.00158	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	7.88e-06	0.00158	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	7.76e-06	0.00156	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.75e-06	0.00155	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	7.65e-06	0.00153	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	7.25e-06	0.00145	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	7.23e-06	0.00145	CbGpPWpGaD
Citalopram—SLC6A4—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	7.22e-06	0.00145	CbGpPWpGaD
Citalopram—CHRM1—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	7.18e-06	0.00144	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	7.18e-06	0.00144	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	7.16e-06	0.00143	CbGpPWpGaD
Citalopram—SLC6A3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	7.12e-06	0.00143	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	7.12e-06	0.00143	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	7.05e-06	0.00141	CbGpPWpGaD
Citalopram—SLC6A3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	6.99e-06	0.0014	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.9e-06	0.00138	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	6.8e-06	0.00136	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	6.63e-06	0.00133	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	6.6e-06	0.00132	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	6.5e-06	0.0013	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.46e-06	0.00129	CbGpPWpGaD
Citalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	6.2e-06	0.00124	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CD55—peripheral nervous system neoplasm	6.19e-06	0.00124	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.98e-06	0.0012	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.84e-06	0.00117	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	5.72e-06	0.00115	CbGpPWpGaD
Citalopram—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	5.63e-06	0.00113	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GNS—peripheral nervous system neoplasm	5.6e-06	0.00112	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—NTS—peripheral nervous system neoplasm	5.6e-06	0.00112	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—NTS—peripheral nervous system neoplasm	5.58e-06	0.00112	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.5e-06	0.0011	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—NTS—peripheral nervous system neoplasm	5.49e-06	0.0011	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	5.48e-06	0.0011	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	5.41e-06	0.00108	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	5.37e-06	0.00108	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—NME1—peripheral nervous system neoplasm	5.37e-06	0.00108	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CD55—peripheral nervous system neoplasm	5.37e-06	0.00108	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	5.36e-06	0.00107	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CD55—peripheral nervous system neoplasm	5.35e-06	0.00107	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.32e-06	0.00107	CbGpPWpGaD
Citalopram—SLC6A3—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	5.28e-06	0.00106	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	5.28e-06	0.00106	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	5.27e-06	0.00106	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CD55—peripheral nervous system neoplasm	5.26e-06	0.00106	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—COX2—peripheral nervous system neoplasm	5.17e-06	0.00104	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.97e-06	0.000996	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.91e-06	0.000985	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	4.9e-06	0.000982	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.89e-06	0.000981	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.73e-06	0.000948	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	4.69e-06	0.00094	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	4.67e-06	0.000937	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.66e-06	0.000934	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	4.6e-06	0.000922	CbGpPWpGaD
Citalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	4.54e-06	0.00091	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.52e-06	0.000905	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	4.44e-06	0.000891	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.4e-06	0.000882	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	4.33e-06	0.000867	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	4.32e-06	0.000867	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.3e-06	0.000861	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.26e-06	0.000853	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.24e-06	0.000851	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.24e-06	0.00085	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.23e-06	0.000847	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	4.22e-06	0.000846	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.18e-06	0.000837	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.16e-06	0.000834	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	4.14e-06	0.000831	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.1e-06	0.000822	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.09e-06	0.000819	CbGpPWpGaD
Citalopram—SLC6A3—Neuronal System—HRAS—peripheral nervous system neoplasm	4.05e-06	0.000812	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	4.05e-06	0.000811	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.02e-06	0.000806	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	3.99e-06	0.0008	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	3.98e-06	0.000797	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	3.93e-06	0.000788	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	3.92e-06	0.000786	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	3.91e-06	0.000785	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	3.9e-06	0.000782	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	3.89e-06	0.000781	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.87e-06	0.000776	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	3.86e-06	0.000773	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	3.84e-06	0.00077	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	3.81e-06	0.000764	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	3.72e-06	0.000746	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	3.71e-06	0.000744	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	3.67e-06	0.000736	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	3.65e-06	0.000732	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.6e-06	0.000721	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.54e-06	0.00071	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	3.47e-06	0.000696	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	3.47e-06	0.000695	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—ENO2—peripheral nervous system neoplasm	3.39e-06	0.000681	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.39e-06	0.00068	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	3.37e-06	0.000675	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	3.23e-06	0.000647	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	3.11e-06	0.000623	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.99e-06	0.000598	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.94e-06	0.000589	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.93e-06	0.000587	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	2.93e-06	0.000587	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.9e-06	0.000582	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.88e-06	0.000578	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—BCHE—peripheral nervous system neoplasm	2.87e-06	0.000575	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	2.85e-06	0.000571	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.79e-06	0.00056	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.77e-06	0.000554	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	2.75e-06	0.000552	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.74e-06	0.000549	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—TH—peripheral nervous system neoplasm	2.7e-06	0.000541	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	2.62e-06	0.000525	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	2.6e-06	0.000521	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.59e-06	0.000519	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.58e-06	0.000517	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	2.56e-06	0.000512	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.54e-06	0.000509	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.54e-06	0.000509	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.51e-06	0.000504	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.51e-06	0.000502	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	2.49e-06	0.0005	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.47e-06	0.000495	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	2.41e-06	0.000483	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	2.41e-06	0.000482	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	2.4e-06	0.000481	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.4e-06	0.00048	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.39e-06	0.000479	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.35e-06	0.000471	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	2.25e-06	0.000451	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	2.21e-06	0.000444	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	2.21e-06	0.000442	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GNAS—peripheral nervous system neoplasm	2.2e-06	0.000441	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.2e-06	0.000441	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.19e-06	0.000439	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.16e-06	0.000433	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	2.16e-06	0.000433	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.16e-06	0.000433	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.11e-06	0.000423	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	2.08e-06	0.000417	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.06e-06	0.000413	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	2.04e-06	0.000409	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	2.04e-06	0.000408	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	2.03e-06	0.000407	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.94e-06	0.000389	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	1.91e-06	0.000384	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.79e-06	0.00036	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.76e-06	0.000354	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.72e-06	0.000346	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	1.7e-06	0.00034	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	1.67e-06	0.000334	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	1.66e-06	0.000332	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.65e-06	0.00033	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	1.62e-06	0.000325	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.58e-06	0.000316	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.56e-06	0.000313	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.56e-06	0.000312	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.55e-06	0.000311	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.53e-06	0.000307	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.53e-06	0.000306	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.53e-06	0.000306	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.52e-06	0.000305	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.5e-06	0.000301	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.39e-06	0.000279	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.33e-06	0.000267	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.32e-06	0.000265	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.31e-06	0.000263	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.3e-06	0.00026	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.28e-06	0.000256	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.27e-06	0.000254	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.27e-06	0.000254	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.25e-06	0.000251	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.21e-06	0.000242	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.2e-06	0.000241	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.19e-06	0.000238	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.16e-06	0.000232	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.14e-06	0.000228	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.13e-06	0.000227	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.12e-06	0.000224	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.11e-06	0.000222	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.1e-06	0.000221	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.1e-06	0.00022	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.09e-06	0.000219	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.09e-06	0.000218	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.08e-06	0.000216	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.06e-06	0.000213	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.02e-06	0.000205	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1e-06	0.000201	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1e-06	0.000201	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1e-06	0.000201	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.88e-07	0.000198	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.86e-07	0.000198	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.19e-07	0.000184	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.16e-07	0.000184	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.02e-07	0.000181	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.56e-07	0.000172	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.53e-07	0.000171	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.4e-07	0.000168	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.11e-07	0.000163	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.76e-07	0.000155	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.03e-07	0.000141	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.01e-07	0.00014	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.9e-07	0.000138	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.85e-07	0.000137	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.72e-07	0.000135	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.7e-07	0.000134	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.6e-07	0.000132	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	6.07e-07	0.000122	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	5.94e-07	0.000119	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.94e-07	0.000119	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.92e-07	0.000119	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.82e-07	0.000117	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	4.58e-07	9.19e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	4.48e-07	8.97e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	4.22e-07	8.45e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	3.57e-07	7.16e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	2.76e-07	5.53e-05	CbGpPWpGaD
